Comorbidities in patients with eosinophilic granulomatosis with polyangiitis and severe uncontrolled asthma: a retrospective analysis of US health insurance claims data [PDF]
Paul Dolin +9 more
openalex +1 more source
M24 3-year real world outcomes with benralizumab for severe eosinophilic asthma [PDF]
, 2023 H. P. Palmer +5 more
openalex +1 more source
A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab [PDF]
, 2012 Azusa Okude +4 more
openalex +1 more source
Sputum immunoglobulin E levels correlate with eosinophilic airway regardless of atopy
Allergy, Asthma & Clinical ImmunologyImmunoglobulin E (IgE) is a key molecule that induces mast cell activation in allergic inflammation and contributes to type 2/eosinophilic inflammation in asthmatic airways.
Hyo-In Rhyou +4 more
doaj +1 more source
Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients With Severe Eosinophilic Asthma [PDF]
, 2018 M Kurosawa, E Sutoh
openalex +1 more source
Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
, 2022 A. Gómez-Bastero Fernández +6 more
openalex +2 more sources
EE135 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Colombia [PDF]
, 2022 J Ordoñez, Ariana Ordoñez
openalex +1 more source
Estimated Asthma Exacerbation Reduction from Omalizumab in an Severe Eosinophilic Asthma Population [PDF]
, 2015 Thomas B. Casale +7 more
openalex +1 more source